|
OMIM |
Link |
Information gain |
01 |
|
sebaceous gland hyperplasia, familial presenile
|
[NCBI]
|
0.00368976
|
|
|
AIMAH
|
[NCBI]
|
0.00195622
|
|
|
PCNA
|
[NCBI]
|
0.0011725
|
|
|
IH
|
[NCBI]
|
0.000987202
|
|
|
HFH
|
[NCBI]
|
0.000696005
|
|
|
HHF7
|
[NCBI]
|
0.000614201
|
|
|
amelogenesis imperfecta, hypoplastic type
|
[NCBI]
|
0.000614201
|
|
|
osteogenesis imperfecta, type v
|
[NCBI]
|
0.000614201
|
|
|
PTH
|
[NCBI]
|
0.000600868
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.00056124
|
|
|
indifference to pain, congenital, autosomal dominant
|
[NCBI]
|
0.00056124
|
|
|
TRICY1
|
[NCBI]
|
0.00056124
|
|
|
PPPP
|
[NCBI]
|
0.000490783
|
|
|
MNG1
|
[NCBI]
|
0.000464919
|
|
|
MG
|
[NCBI]
|
0.000449715
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.000442845
|
|
|
pulmonary alveolar proteinosis, acquired
|
[NCBI]
|
0.000406563
|
|
|
focal epithelial hyperplasia, oral
|
[NCBI]
|
0.000381202
|
|
|
ZLS
|
[NCBI]
|
0.000377429
|
|
|
HHF1
|
[NCBI]
|
0.000354182
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
0.000323024
|
|
|
ST8
|
[NCBI]
|
0.000314174
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000313362
|
|
|
HRPT1
|
[NCBI]
|
0.000255813
|
|
|
EGF
|
[NCBI]
|
0.000206217
|
|
|
LAM
|
[NCBI]
|
0.0001917
|
|
|
hyperparathyroidism, primary, caused by water clear cell hyperplasia
|
[NCBI]
|
0.000190471
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
0.000176821
|
|
|
proteus syndrome
|
[NCBI]
|
0.000173991
|
|
|
HHC1
|
[NCBI]
|
0.000168794
|
|
|
MEN2A
|
[NCBI]
|
0.000168336
|
|
|
fibromuscular dysplasia of arteries
|
[NCBI]
|
0.000164669
|
|
|
CF
|
[NCBI]
|
0.000163081
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
0.000161226
|
|
|
MEN1
|
[NCBI]
|
0.000153451
|
|
|
HHF2
|
[NCBI]
|
0.000145498
|
|
|
MTS
|
[NCBI]
|
0.000138422
|
|
|
MEN2B
|
[NCBI]
|
0.000124196
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
0.000117817
|
|
|
GIP
|
[NCBI]
|
0.000109283
|
|
|
BWS
|
[NCBI]
|
0.000104453
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
0.000103279
|
|
|
NSHPT
|
[NCBI]
|
0.000100496
|
|
|
CACP
|
[NCBI]
|
9.55791e-05
|
|
|
pulmonary nodular lymphoid hyperplasia, familial
|
[NCBI]
|
9.52032e-05
|
|
|
PPNAD2
|
[NCBI]
|
9.52032e-05
|
|
|
insensitivity to pain with hyperplastic myelinopathy
|
[NCBI]
|
9.52032e-05
|
|
|
cheilitis glandularis
|
[NCBI]
|
9.52032e-05
|
|
|
focal epithelial hyperplasia of the oral mucosa
|
[NCBI]
|
9.52032e-05
|
|
|
GHRH
|
[NCBI]
|
8.30598e-05
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
8.27361e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
7.98755e-05
|
|
|
CASR
|
[NCBI]
|
7.89979e-05
|
|
|
HDC
|
[NCBI]
|
7.68151e-05
|
|
|
PDE11A
|
[NCBI]
|
7.59964e-05
|
|
|
KLK3
|
[NCBI]
|
7.49398e-05
|
|
|
PPH1
|
[NCBI]
|
7.48559e-05
|
|
|
short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities
|
[NCBI]
|
7.27761e-05
|
|
|
hemifacial myohyperplasia
|
[NCBI]
|
7.27761e-05
|
|
|
RUNX3
|
[NCBI]
|
6.57029e-05
|
|
|
CD
|
[NCBI]
|
6.47955e-05
|
|
|
FGF7
|
[NCBI]
|
6.44509e-05
|
|
|
pacman dysplasia
|
[NCBI]
|
6.43395e-05
|
|
|
CNC1
|
[NCBI]
|
6.34752e-05
|
|
|
INSL3
|
[NCBI]
|
6.28772e-05
|
|
|
LIP
|
[NCBI]
|
6.26996e-05
|
|
|
MUC1
|
[NCBI]
|
6.12923e-05
|
|
|
PRL
|
[NCBI]
|
6.03964e-05
|
|
|
TNF
|
[NCBI]
|
5.87229e-05
|
|
|
CCK
|
[NCBI]
|
5.77658e-05
|
|
|
PTHLH
|
[NCBI]
|
5.63231e-05
|
|
|
SRS
|
[NCBI]
|
5.56256e-05
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
5.48264e-05
|
|
|
CDG1D
|
[NCBI]
|
5.48264e-05
|
|
|
tuftsin deficiency
|
[NCBI]
|
5.48264e-05
|
|
|
SPDEF
|
[NCBI]
|
5.1718e-05
|
|
|
keratin 6, hair follicle
|
[NCBI]
|
5.1718e-05
|
|
|
RRAS
|
[NCBI]
|
5.1718e-05
|
|
|
whim syndrome
|
[NCBI]
|
4.89391e-05
|
|
|
AICDA
|
[NCBI]
|
4.85695e-05
|
|
|
TNC
|
[NCBI]
|
4.74265e-05
|
|
|
PPNAD1
|
[NCBI]
|
4.6661e-05
|
|
|
precocious puberty, male-limited
|
[NCBI]
|
4.4675e-05
|
|
|
AIH2
|
[NCBI]
|
4.4675e-05
|
|
|
SLE
|
[NCBI]
|
4.3351e-05
|
|
|
erythroleukemia, familial
|
[NCBI]
|
4.29157e-05
|
|
|
TS
|
[NCBI]
|
4.15295e-05
|
|
|
leiomyomatosis, esophageal and vulval, with nephropathy
|
[NCBI]
|
4.13375e-05
|
|
|
MTC
|
[NCBI]
|
3.99074e-05
|
|
|
wagr syndrome
|
[NCBI]
|
3.99074e-05
|
|
|
BAX
|
[NCBI]
|
3.98027e-05
|
|
|
ABCC8
|
[NCBI]
|
3.90119e-05
|
|
|
WISP2
|
[NCBI]
|
3.79921e-05
|
|
|
ENAH
|
[NCBI]
|
3.79921e-05
|
|
|
MAP2K2
|
[NCBI]
|
3.79921e-05
|
|
|
NAB2
|
[NCBI]
|
3.79921e-05
|
|
|
TLE3
|
[NCBI]
|
3.79921e-05
|
|
|
NR1I3
|
[NCBI]
|
3.79921e-05
|
|
|
KRT6B
|
[NCBI]
|
3.79921e-05
|
|
|
CABLES1
|
[NCBI]
|
3.79921e-05
|
|
|
GDF11
|
[NCBI]
|
3.79921e-05
|
|
|
TLX2
|
[NCBI]
|
3.79921e-05
|
|
|
FOXL1
|
[NCBI]
|
3.79921e-05
|
|
|
MBP
|
[NCBI]
|
3.78299e-05
|
|
|
RET
|
[NCBI]
|
3.75722e-05
|
|
|
LPL
|
[NCBI]
|
3.71515e-05
|
|
|
BDNF
|
[NCBI]
|
3.45336e-05
|
|
|
DAP
|
[NCBI]
|
3.39457e-05
|
|
|
NKX3A
|
[NCBI]
|
3.28454e-05
|
|
|
LYPD3
|
[NCBI]
|
3.28454e-05
|
|
|
KCNN4
|
[NCBI]
|
3.28454e-05
|
|
|
SPRY2
|
[NCBI]
|
3.28454e-05
|
|
|
IQGAP1
|
[NCBI]
|
3.28454e-05
|
|
|
BHLHB2
|
[NCBI]
|
3.28454e-05
|
|
|
NAB1
|
[NCBI]
|
3.28454e-05
|
|
|
MECT1
|
[NCBI]
|
3.28454e-05
|
|
|
LYN
|
[NCBI]
|
3.28454e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
3.17086e-05
|
|
|
AFP
|
[NCBI]
|
3.16049e-05
|
|
|
AVP
|
[NCBI]
|
3.1522e-05
|
|
|
RTD
|
[NCBI]
|
3.09434e-05
|
|
|
EGFR
|
[NCBI]
|
3.07694e-05
|
|
|
MAS
|
[NCBI]
|
3.07151e-05
|
|
|
SLC6A4
|
[NCBI]
|
3.00632e-05
|
|
|
CEACAM1
|
[NCBI]
|
2.95872e-05
|
|
|
GSD
|
[NCBI]
|
2.95253e-05
|
|
|
TMEFF2
|
[NCBI]
|
2.95224e-05
|
|
|
IL25
|
[NCBI]
|
2.95224e-05
|
|
|
thymosin, beta-15
|
[NCBI]
|
2.95224e-05
|
|
|
ERRFI1
|
[NCBI]
|
2.95224e-05
|
|
|
ANXA7
|
[NCBI]
|
2.95224e-05
|
|
|
KRT6A
|
[NCBI]
|
2.95224e-05
|
|
|
REG1A
|
[NCBI]
|
2.95224e-05
|
|
|
AMHR2
|
[NCBI]
|
2.95224e-05
|
|
|
RA
|
[NCBI]
|
2.94176e-05
|
|
|
thrombocythemia, essential
|
[NCBI]
|
2.88659e-05
|
|
|
KIT
|
[NCBI]
|
2.75309e-05
|
|
|
HGF
|
[NCBI]
|
2.74304e-05
|
|
|
VDR
|
[NCBI]
|
2.72127e-05
|
|
|
LTB4R
|
[NCBI]
|
2.70655e-05
|
|
|
LMO4
|
[NCBI]
|
2.70655e-05
|
|
|
PPP2R1B
|
[NCBI]
|
2.70655e-05
|
|
|
RPA1
|
[NCBI]
|
2.70655e-05
|
|
|
ALG3
|
[NCBI]
|
2.70655e-05
|
|
|
PRDM1
|
[NCBI]
|
2.70655e-05
|
|
|
CTSE
|
[NCBI]
|
2.70655e-05
|
|
|
SMAD7
|
[NCBI]
|
2.70655e-05
|
|
|
donohue syndrome
|
[NCBI]
|
2.70548e-05
|
|
|
NPHP1
|
[NCBI]
|
2.5453e-05
|
|
|
ICOSLG
|
[NCBI]
|
2.51187e-05
|
|
|
GCGR
|
[NCBI]
|
2.51187e-05
|
|
|
GIST
|
[NCBI]
|
2.51031e-05
|
|
|
UGB
|
[NCBI]
|
2.4871e-05
|
|
|
fraser syndrome
|
[NCBI]
|
2.44807e-05
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
2.44807e-05
|
|
|
CDK4
|
[NCBI]
|
2.3567e-05
|
|
|
CTNNA1
|
[NCBI]
|
2.35089e-05
|
|
|
TGM2
|
[NCBI]
|
2.35089e-05
|
|
|
TACSTD2
|
[NCBI]
|
2.35089e-05
|
|
|
PPARBP
|
[NCBI]
|
2.35089e-05
|
|
|
SFTPD
|
[NCBI]
|
2.35089e-05
|
|
|
ABP1
|
[NCBI]
|
2.33554e-05
|
|
|
CCND1
|
[NCBI]
|
2.27347e-05
|
|
|
FGF23
|
[NCBI]
|
2.26022e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
2.2589e-05
|
|
|
CVID
|
[NCBI]
|
2.23235e-05
|
|
|
WNT1
|
[NCBI]
|
2.21388e-05
|
|
|
MAP2K1
|
[NCBI]
|
2.21388e-05
|
|
|
THBS1
|
[NCBI]
|
2.21388e-05
|
|
|
BCNS
|
[NCBI]
|
2.1697e-05
|
|
|
EPO
|
[NCBI]
|
2.08942e-05
|
|
|
CRH
|
[NCBI]
|
2.04502e-05
|
|
|
TYMS
|
[NCBI]
|
2.01053e-05
|
|
|
PRG4
|
[NCBI]
|
1.98958e-05
|
|
|
APAF1
|
[NCBI]
|
1.98958e-05
|
|
|
FPRL1
|
[NCBI]
|
1.98958e-05
|
|
|
KRAS
|
[NCBI]
|
1.91777e-05
|
|
|
ANXA1
|
[NCBI]
|
1.89548e-05
|
|
|
GFAP
|
[NCBI]
|
1.83988e-05
|
|
|
TXNIP
|
[NCBI]
|
1.81047e-05
|
|
|
ZNF198
|
[NCBI]
|
1.81047e-05
|
|
|
KRT17
|
[NCBI]
|
1.81047e-05
|
|
|
TSHB
|
[NCBI]
|
1.81047e-05
|
|
|
ATF4
|
[NCBI]
|
1.73302e-05
|
|
|
IL9
|
[NCBI]
|
1.73302e-05
|
|
|
H2AFX
|
[NCBI]
|
1.59637e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.59637e-05
|
|
|
IRF1
|
[NCBI]
|
1.59637e-05
|
|
|
CDKN1B
|
[NCBI]
|
1.59637e-05
|
|
|
GJB2
|
[NCBI]
|
1.55164e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.5443e-05
|
|
|
NPY
|
[NCBI]
|
1.54289e-05
|
|
|
PPARD
|
[NCBI]
|
1.53553e-05
|
|
|
NGFR
|
[NCBI]
|
1.53539e-05
|
|
|
NIDDM
|
[NCBI]
|
1.52234e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
1.45758e-05
|
|
|
TCOF
|
[NCBI]
|
1.39643e-05
|
|
|
CHGA
|
[NCBI]
|
1.32918e-05
|
|
|
EDA
|
[NCBI]
|
1.32918e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.30123e-05
|
|
|
MSTN
|
[NCBI]
|
1.28494e-05
|
|
|
REST
|
[NCBI]
|
1.28494e-05
|
|
|
OCP
|
[NCBI]
|
1.24879e-05
|
|
|
CTSL
|
[NCBI]
|
1.24307e-05
|
|
|
PTPN11
|
[NCBI]
|
1.24307e-05
|
|
|
CHAT
|
[NCBI]
|
1.23396e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
1.20335e-05
|
|
|
CDKN1A
|
[NCBI]
|
1.20335e-05
|
|
|
PAM
|
[NCBI]
|
1.20335e-05
|
|
|
SHBG
|
[NCBI]
|
1.19478e-05
|
|
|
SDHD
|
[NCBI]
|
1.1656e-05
|
|
|
CCL21
|
[NCBI]
|
1.1656e-05
|
|
|
HBB
|
[NCBI]
|
1.14811e-05
|
|
|
IRS2
|
[NCBI]
|
1.12965e-05
|
|
|
SVAS
|
[NCBI]
|
1.11996e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.11277e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.10326e-05
|
|
|
CAT
|
[NCBI]
|
1.093e-05
|
|
|
INSR
|
[NCBI]
|
1.05159e-05
|
|
|
CSF2
|
[NCBI]
|
1.03125e-05
|
|
|
PDGFB
|
[NCBI]
|
9.72419e-06
|
|
|
CDKN2A
|
[NCBI]
|
9.61621e-06
|
|
|
PPARA
|
[NCBI]
|
9.54308e-06
|
|
|
MMP3
|
[NCBI]
|
9.44759e-06
|
|
|
ZNF145
|
[NCBI]
|
9.44759e-06
|
|
|
VASP
|
[NCBI]
|
9.18169e-06
|
|
|
PAEP
|
[NCBI]
|
9.18169e-06
|
|
|
FHIT
|
[NCBI]
|
9.18169e-06
|
|
|
WT1
|
[NCBI]
|
9.17622e-06
|
|
|
BCL6
|
[NCBI]
|
8.92581e-06
|
|
|
KRT20
|
[NCBI]
|
8.79437e-06
|
|
|
SLC18A3
|
[NCBI]
|
8.44176e-06
|
|
|
CHEK2
|
[NCBI]
|
8.44176e-06
|
|
|
ACHE
|
[NCBI]
|
8.03419e-06
|
|
|
CTNNB1
|
[NCBI]
|
7.99118e-06
|
|
|
TH
|
[NCBI]
|
7.88974e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
7.77731e-06
|
|
|
LHCGR
|
[NCBI]
|
7.5705e-06
|
|
|
F2R
|
[NCBI]
|
7.5705e-06
|
|
|
JAK3
|
[NCBI]
|
7.5705e-06
|
|
|
APOE
|
[NCBI]
|
7.53886e-06
|
|
|
ZS
|
[NCBI]
|
6.88237e-06
|
|
|
ACH
|
[NCBI]
|
6.79295e-06
|
|
|
APC
|
[NCBI]
|
6.38263e-06
|
|
|
AMH
|
[NCBI]
|
6.2901e-06
|
|
|
TFF3
|
[NCBI]
|
6.13228e-06
|
|
|
SDC2
|
[NCBI]
|
5.96826e-06
|
|
|
apc gene
|
[NCBI]
|
5.89007e-06
|
|
|
LCN2
|
[NCBI]
|
5.8233e-06
|
|
|
BCL2
|
[NCBI]
|
5.67525e-06
|
|
|
PEDF
|
[NCBI]
|
5.58603e-06
|
|
|
MSH2
|
[NCBI]
|
5.53125e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
5.53125e-06
|
|
|
KCNQ1
|
[NCBI]
|
5.39115e-06
|
|
|
PGR
|
[NCBI]
|
5.38006e-06
|
|
|
MPO
|
[NCBI]
|
5.35939e-06
|
|
|
CCL2
|
[NCBI]
|
4.99279e-06
|
|
|
AR
|
[NCBI]
|
4.73217e-06
|
|
|
STAT5A
|
[NCBI]
|
4.50804e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
4.50804e-06
|
|
|
TSHR
|
[NCBI]
|
4.50804e-06
|
|
|
MAP3K5
|
[NCBI]
|
4.39438e-06
|
|
|
PTN
|
[NCBI]
|
4.17539e-06
|
|
|
KITLG
|
[NCBI]
|
4.17539e-06
|
|
|
TFPI
|
[NCBI]
|
4.15997e-06
|
|
|
PTGS2
|
[NCBI]
|
3.86642e-06
|
|
|
ACP5
|
[NCBI]
|
3.74425e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
3.67253e-06
|
|
|
TNFSF6
|
[NCBI]
|
3.53939e-06
|
|
|
TF
|
[NCBI]
|
3.48387e-06
|
|
|
SOD2
|
[NCBI]
|
3.45528e-06
|
|
|
ALB
|
[NCBI]
|
3.36995e-06
|
|
|
SPP1
|
[NCBI]
|
3.33716e-06
|
|
|
SLC2A4
|
[NCBI]
|
3.22604e-06
|
|
|
MLH1
|
[NCBI]
|
3.14281e-06
|
|
|
AIS
|
[NCBI]
|
3.11786e-06
|
|
|
LEPR
|
[NCBI]
|
3.06147e-06
|
|
|
GNRH1
|
[NCBI]
|
2.87882e-06
|
|
|
VIM
|
[NCBI]
|
2.68142e-06
|
|
|
GCK
|
[NCBI]
|
2.54101e-06
|
|
|
GRP
|
[NCBI]
|
2.40673e-06
|
|
|
RASA1
|
[NCBI]
|
2.3418e-06
|
|
|
G6PD
|
[NCBI]
|
2.28871e-06
|
|
|
FGFR1
|
[NCBI]
|
2.21619e-06
|
|
|
EPOR
|
[NCBI]
|
2.0379e-06
|
|
|
TP53
|
[NCBI]
|
1.97344e-06
|
|
|
BL
|
[NCBI]
|
1.6805e-06
|
|
|
F3
|
[NCBI]
|
1.63495e-06
|
|
|
AHR
|
[NCBI]
|
1.5873e-06
|
|
|
FRAP1
|
[NCBI]
|
1.48891e-06
|
|
|
GDNF
|
[NCBI]
|
1.40862e-06
|
|
|
ILK
|
[NCBI]
|
1.38845e-06
|
|
|
CDK2
|
[NCBI]
|
1.26344e-06
|
|
|
CFTR
|
[NCBI]
|
1.03445e-06
|
|
|
ACE
|
[NCBI]
|
1.01174e-06
|
|
|
ABCC1
|
[NCBI]
|
9.19242e-07
|
|
|
PI
|
[NCBI]
|
8.79875e-07
|
|
|
MB
|
[NCBI]
|
6.97596e-07
|
|
|
MAP2
|
[NCBI]
|
5.95028e-07
|
|
|
LEP
|
[NCBI]
|
5.02569e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.56912e-07
|
|
|
ADCYAP1
|
[NCBI]
|
4.39488e-07
|
|
|
TPO
|
[NCBI]
|
3.93101e-07
|
|
|
CRC
|
[NCBI]
|
3.76217e-07
|
|
|
PTK2
|
[NCBI]
|
3.59298e-07
|
|
|
ALD
|
[NCBI]
|
2.92619e-07
|
|
|
FGFR3
|
[NCBI]
|
2.90596e-07
|
|
|
LDLR
|
[NCBI]
|
2.90596e-07
|
|
|
PSEN1
|
[NCBI]
|
2.50176e-07
|
|
|
CP
|
[NCBI]
|
2.4657e-07
|
|
|
FMF
|
[NCBI]
|
2.26406e-07
|
|
|
TNFSF10
|
[NCBI]
|
2.25735e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.98238e-07
|
|
|
XDH
|
[NCBI]
|
1.46552e-07
|
|
|
ALK
|
[NCBI]
|
1.33934e-07
|
|
|
NF1
|
[NCBI]
|
1.13353e-07
|
|
|
SHH
|
[NCBI]
|
9.52693e-08
|
|
|
GAPDH
|
[NCBI]
|
9.52693e-08
|
|
|
ADM
|
[NCBI]
|
8.48834e-08
|
|
|
polycystic kidneys
|
[NCBI]
|
5.33015e-08
|
|
|
VIP
|
[NCBI]
|
5.17e-08
|
|
|
NGFB
|
[NCBI]
|
4.83382e-08
|
|
|
CD
|
[NCBI]
|
4.65707e-08
|
|
|
PYY
|
[NCBI]
|
3.83102e-08
|
|
|
GJA1
|
[NCBI]
|
2.97165e-08
|
|
|
IAPP
|
[NCBI]
|
1.1694e-08
|
|
|
VEGF
|
[NCBI]
|
7.3897e-09
|
|
|
ACPP
|
[NCBI]
|
7.04972e-09
|
|